USPTO serial 90758536
NAVIGATOR365
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Jun 25, 2024
- Examiner
- NEHMER, JASON ROBERT
- Law office
- FILE REPOSITORY (FRANCONIA)
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with NAVIGATOR365?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Owner
PRECISION FOR MEDICINE NL B.V.
GENT, BE
GHENT, BE
Bethesda, MD, US
Bethesda, MD, US
Bethesda, MD, US
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Donna H. Hartman
Donna H. Hartman OLENDERFELDMAN LLP422 MORRIS AVENUESUMMIT, NJ 07901United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 035 | Business services, namely, advertising, marketing, promotional consultancy, and advisory services; Electronic data collection, analysis, and data submission services of quality metric data for business purposes in the life sciences industry in the fields of medicine, pharmaceutical, biopharmaceutical, medical devices, nutrition, and health care; Business research services, namely, the creation, collection, analysis, provision of statistical and commercial data, and reporting in the life sciences industry in the fields of medicine, pharmaceutical, biopharmaceutical, medical devices, nutrition, and health care; Market research services in the nature of measuring, tracking, and demographic modeling of audiences for omnichannel activities in the life sciences industry in the fields of medicine, pharmaceutical, biopharmaceutical, medical devices, nutrition, and health care; Market research services in the nature of tracking and measuring audience viewing of, exposure to, and reactions to omnichannel campaign measurement and analysis, and demographic and geographic studies; Market research services in the nature of conducting audience validation services to verify the market impressions and demographics in the life sciences industry in the fields of medicine, pharmaceutical, biopharmaceutical, medical devices, nutrition, and health care; Delivery of solutions and other services, namely, marketing research services, development of marketing strategies and concepts, relating to and for use in marketing, sales measurement and analysis, product advertising and marketing strategies and tools, customer preferences and demands, product innovation and development, customers' purchasing decisions, histories and behaviors, competitor and market analysis, in the fields of medicine, pharmaceutical, biopharmaceutical, medical devices, nutrition, and health care; Business research services in the nature of analyzing, manipulating, and measuring data obtained from market data and the customization and personalization of data for clients to engage in solutions, generate reports and utilize dashboard analytics | ACTIVE | — |
| 041 | Providing nondownloadable electronic publications in the nature of interactive, integrated, cloud-based and analytical reports in the fields of audience measurement, media exposure measurement, market research and business research; Delivery of solutions and other services, namely, providing online nondownloadable publications in the nature of data, charts, and tables in customizable reports, in the fields of marketing, sales measurement and analysis, product advertising and marketing strategies and tools, customer preferences and demands, product innovation and development, customers' purchasing decisions, histories and behaviors, competitor and market analysis, in the fields of medicine, pharmaceutical, biopharmaceutical, medical devices, nutrition, and health care | ACTIVE | — |
| 042 | Providing software as a service (SAAS) services featuring cloud-based software for the life sciences industry for analyzing omnichannel customer data, customer relationship management, drafting industry reports, etc.in the fields of medicine, pharmaceutical, biopharmaceutical, medical devices, nutrition, and health care; Software as a service (SAAS) services, featuring software for industry analytics and business intelligence in the life sciences industry in the fields of medicine, pharmaceutical, biopharmaceutical, medical devices, nutrition, and health care; Providing software as a service (SAAS) services featuring software that enables users to search, analyze, and manipulate market data to generate reports and utilize dashboard analytics for the life sciences industry in the fields of medicine, pharmaceutical, biopharmaceutical, medical devices, nutrition, and health care; Delivery of solutions and other services, namely, providing online nondownloadable software for measuring and analyzing omnichannel customer data relating to and for use in marketing, sales measurement and analysis, product advertising and marketing strategies and tools, customer preferences and demands, product innovation and development, customers' purchasing decisions, histories and behaviors, competitor and market analysis, in the fields of medicine, pharmaceutical, biopharmaceutical, medical devices, nutrition, and health care | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by PRECISION FOR MEDICINE NL B.V.
- Other trademarks owned by PRECISION AQ (BE) NV
- Other trademarks owned by Precision Medicine Group, LLC
- Other trademarks owned by Precision Medicine Group, LLC
- Other trademarks owned by Precision Medicine Group, LLC
- Other trademarks in Class 035
- Other trademarks in Class 041
- Other trademarks in Class 042
- Similar marks named NAVIGATOR365
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 7, 2026 | ASGN | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | — |
| Jun 10, 2026 | ASGN | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | — |
| Jun 25, 2024 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Jun 25, 2024 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Apr 9, 2024 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Apr 9, 2024 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Mar 20, 2024 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Mar 5, 2024 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Mar 4, 2024 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Mar 4, 2024 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 4, 2024 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Dec 4, 2023 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Dec 4, 2023 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Dec 4, 2023 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| May 18, 2023 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| May 18, 2023 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| May 18, 2023 | CNSL | SUSPENSION LETTER WRITTEN | — |
| May 18, 2023 | DOCK | ASSIGNED TO EXAMINER | — |
| May 21, 2022 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| May 20, 2022 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| May 20, 2022 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Nov 20, 2021 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 20, 2021 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 20, 2021 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 17, 2021 | DOCK | ASSIGNED TO EXAMINER | — |
| Sep 2, 2021 | AMPX | PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED | — |
| Sep 2, 2021 | ALIE | ASSIGNED TO LIE | — |
| Aug 27, 2021 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jun 15, 2021 | PARI | TEAS VOLUNTARY AMENDMENT RECEIVED | — |
| Jun 10, 2021 | NWAP | NEW APPLICATION ENTERED | — |